Results 31 to 40 of about 18,435 (154)

Topical prostaglandin analogues and conjunctival inflammation in uveitic glaucoma. [PDF]

open access: yes, 2012
20.02.14 KB. Ok to add published verson to spiral, OA paper.A pilot study to determine whether topical prostaglandin analogues alter the expression of conjunctival inflammatory markers in patients with uveitic glaucoma.Prospective, single-masked case ...
Sallam, A   +3 more
core   +1 more source

Comparative study of recurrence after pterygium excision with conjunctival autografting and amniotic membrane transplantation [PDF]

open access: yes, 2016
Introduction: Pterygium is ocular surface lesion thought to originate from damage to limbal stem cells by chronic ultra violet light exposure. It has high recurrence rates following resection.
Murlimanohar, J.M.   +4 more
core   +1 more source

One-year results of the triple procedure for primary pterygia

open access: yesDelta Journal of Ophthalmology, 2015
Purpose The aim of this work was to study the effectiveness and potential complications of adjunctive intraoperative mitomycin-C (MMC) application combined with limbal-conjunctival autografting after primary pterygium excision. Patients and methods Fifty-
Hisham A Saad   +2 more
doaj   +1 more source

Conjunctival transcriptome in scarring trachoma. [PDF]

open access: yes, 2010
Trachoma is a poorly understood immunofibrogenic disease process, initiated by Chlamydia trachomatis. Differences in conjunctival gene expression profiles between Ethiopians with trachomatous trichiasis (with [TTI] or without [TT] inflammation) and ...
Saul N. Rajak   +23 more
core   +1 more source

An Overview of Corneal Topography and Visual Outcomes after Different Pterygium Surgeries: An Interventional Case Series Study

open access: yesVan Tıp Dergisi, 2023
INTRODUCTION: To investigate corneal topography and visual outcomes after different pterygium surgical techniques using Pentacam Scheimpflug device METHODS: Ninety-eight unilateral primary nasal pterygium patients underwent surgery under topical ...
Yusuf Cem Yilmaz   +2 more
doaj   +1 more source

Donor site management in primary pterygium excision with conjunctival autograft – Less is more!

open access: yesTNOA Journal of Ophthalmic Science and Research, 2021
Purpose: The aim of this study is to assess spontaneous healing of the conjunctival donor site after primary pterygium surgery and its implications.
Radhika Natarajan, Ankit Anil Harwani
doaj   +1 more source

Pterygium excision followed by sutureless and gluefree infero-temporal conjunctival autograft

open access: yesDelhi Journal of Ophthalmology, 2019
Introduction: There are various methods available at present to reduce the recurrence after pterygium excision and the one in the trend is the sutureless and gluefree conjunctival autografting which is gaining popularity for it’s ease and better results ...
Poonam Bhargava   +2 more
doaj   +1 more source

A Comparative study of Autologous Blood versus Conventional Conjunctival Autograft Surgery for Pterygium [PDF]

open access: yes, 2021
Background: Pterygium is a pink fleshy sub conjunctival growth that covers the white part of your eye over the cornea. Aim: To Compare the Autologous Blood versus Conventional Conjunctival Autograft Surgery for Pterygium.
Singh, Rajiv Kumar, Kumar, Ajay
core   +1 more source

Sutureless and glue-free limbal-conjunctival autograft in primary and recurrent pterygium: A pilot study

open access: yesIndian Journal of Ophthalmology, 2022
Purpose: To evaluate and analyze the outcomes of sutureless and glue-free limbal-conjunctival autografting in cases of primary as well as recurrent pterygium.
Vikas Sharma   +4 more
doaj   +1 more source

Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection? [PDF]

open access: yes, 2006
BACKGROUND: Trachoma, caused by ocular infection with Chlamydia trachomatis, remains the leading infectious cause of blindness and in 2002 was responsible for 3.6% of total global blindness.
Faal Nkoyo   +23 more
core   +1 more source

Home - About - Disclaimer - Privacy